Sirius NeoSight

Sirius NeoSight is a biotech company developing methods to detect subclinical neo-cancers and provide early treatment. Their focus is on identifying nascent cancerous cells before they become symptomatic, enabling proactive therapeutic intervention.

Traction 9/10

HQ unknown

Founded 20238700+ followers

Biotechnology

Updated 6 months ago

Funding

Raised to date

$4.6MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

2 founders

Arnaud Vigneron

Co-Founder and CSO

David Gueyrard

co-fondateur

Product

Features

Sirius NeoSight is a biotech company developing methods to detect subclinical neo-cancers and provide early treatment. Their focus is on identifying nascent cancerous cells before they become symptomatic, enabling proactive therapeutic intervention.